col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt

Verlag: Pharmaceutical Society of Japan

31 Ergebisse       Seite 1

 [1] 
  Original Artikel Journal Datum Titel Autoren Alle Autoren
1 [GO] YAKUGAKU ZASSHI 2023―Nov―30 ウィズコロナ時代の新たな医療に対応できる人材の育成を目指した臨床準備教育におけるオンライン服薬指導実習の試み","A Trial of Practical Training on Online Medication Instructions in Clinical Preparatory Education: Development of Human Resources to Provide New Forms of Medical Care after the COVID-19 Pandemic Susumu Kawano, Hiroaki Kaji, Takayoshi Maiguma, Keisuke Yoshii, Yuichi Tasaka, Yasuhisa Izushi, et al. (+7)
2 [GO] YAKUGAKU ZASSHI 2023―Nov―30 COVID-19流行前後での薬局薬剤師の医療対応の変化に関するアンケート調査","Changes in Attitudes to Medical Care among Pharmacy Pharmacists before and after the COVID-19 Pandemic: A Questionnaire Survey Yu Norikoshi, Yuji Matsunaga, Yuji Uchida, Fukuko Horio, Makoto Anraku, Kanami Suruki, et al. (+3)
3 [GO] Chemical and Pharmaceutical Bulletin 2023―Nov―30 Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond Replacement Kohei Tsuji, Takuya Kobayakawa, Takahiro Ishii, Nobuyo Higashi-Kuwata, Chika Azuma, Kouki Shinohara, et al. (+7)
4 [GO] Chemical and Pharmaceutical Bulletin 2023―Nov―30 <i>In Silico</i> Identification of Inhibitory Compounds for SARS-Cov-2 Papain-Like Protease Kazunori Miwa, Yan Guo, Masayuki Hata, Yoshinori Hirano, Norio Yamamoto, Tyuji Hoshino
5 [GO] BPB Reports 2023―Nov―21 Corrigendum: An <i>in Vitro </i>Short-Term Treatment with Black Tea-Derived Theaflavins Reduced Infectivity of SARS-CoV-2 in Saliva Motohiko Ogawa, Mana Murae, Shuetsu Fukushi, Kohji Noguchi, Hideki Ebihara, Masayoshi Fukasawa
6 [GO] Biological and Pharmaceutical Bulletin 2023―Okt―20 Removal of soluble ACE2 in VeroE6 cells by 17β-estradiol reduces SARS-CoV-2 infectivity Yuta Kyosei, Teruki Yoshimura, Etsuro Ito
7 [GO] BPB Reports 2023―Okt―05 An <i>in Vitro</i> Short-Term Treatment with Black Tea-Derived Theaflavins Reduced Infectivity of SARS-CoV-2 in Saliva Motohiko Ogawa, Mana Murae, Shuetsu Fukushi, Kohji Noguchi, Hideki Ebihara, Masayoshi Fukasawa
8 [GO] YAKUGAKU ZASSHI 2023―Aug―31 かかりつけ薬剤師制度が新型コロナウイルス感染症流行下の脂質異常症患者のアドヒアランスに及ぼす影響","Effect of a Family Pharmacist System on Medication Adherence of Patients with Dyslipidemia during a COVID-19 Epidemic Mamoru Maeda, Yoshitaka Hasegawa, Ryota Tsukioka, Miya Oishi
9 [GO] Chemical and Pharmaceutical Bulletin 2023―Apr―30 Computational Screening of Inhibitory Compounds for SARS-Cov-2 3CL Protease with a Database Consisting of Approved and Investigational Chemicals Kazunori Miwa, Yan Guo, Masayuki Hata, Norio Yamamoto, Tyuji Hoshino
10 [GO] BPB Reports 2023―Apr―06 Survey on Headache During COVID-19 Infection in People with Chronic Headache Masakazu Ishii, Ikumi Ito, Hirotaka Katoh
11 [GO] YAKUGAKU ZASSHI 2023―Feb―28 Pharmacokinetic Study of Antiviral Drugs in Patients with COVID-19 Kei Irie
12 [GO] BPB Reports 2023―Jan―22 Inhibitory Effects of Olive-Derived Phytochemicals on SARS-CoV-2 3C-Like Protease (3CL<sup>pro</sup>) Yoshimitsu Kiriyama, Hiromi Nochi
13 [GO] Biological and Pharmaceutical Bulletin 2022―Okt―07 Safety of remdesivir in 20 children with COVID-19 -case series- Shuji Manabe, Shinsuke Mizuno, Tsuyoshi Jinda, Masashi Kasai
14 [GO] YAKUGAKU ZASSHI 2022―Sep―30 Significant Prolongation of the International Normalized Ratio Associated with COVID-19 Treatment: Possible Drug Interaction with Remdesivir Hidetoshi Ishii, Norio Yokota, Yuki Bando, Katsuya Otori
15 [GO] Chemical and Pharmaceutical Bulletin 2022―Sep―30 Cyclic Phthalate Esters as Liver X Receptor Antagonists with Anti-hepatitis C Virus and Anti-severe Acute Respiratory Syndrome Coronavirus 2 Properties Shiki Saito, Hirofumi Ohashi, Kou Nakamura, Junichiro Otagaki, Kazane Nishioka, Kota Nishiuchi, et al. (+9)
16 [GO] Biological and Pharmaceutical Bulletin 2022―Sep―30 Dihydroceramide Δ4-Desaturase 1 Is Not Involved in SARS-CoV-2 Infection Yasuhiro Hayashi, Kouki Matsuda, Kazunari Tanigawa, Takashi Tanikawa, Kenji Maeda, Kiyoto Tsuchiya
17 [GO] YAKUGAKU ZASSHI 2022―Jul―31 Investigation of Foreign Particles in Moderna COVID-19 Vaccine Hiroko Shibata, Yusuke Nomura, Tsuyoshi Kawakami, Eiichi Yamamoto, Daisuke Ando, Nahoko Uchiyama, et al. (+12)
18 [GO] BPB Reports 2022―Jul―11 Establishment of an Easy and Convenient Anti-SARS-CoV-2 Neutralizing Antibodies Test Flow Starting from Community Pharmacies: Expansion of Pharmacy Functions Suitable During the Novel Coronavirus Era Kazuyuki Niki, Kozo Tada, Katsumi Suezawa, Tomoko Kasashima, Shin Fujisue, Eri Seichi, et al. (+4)
19 [GO] Biological and Pharmaceutical Bulletin 2022―Jun―30 Evaluation of a Webinar for Pharmacists Learning Basic Clinical-Oncology during COVID-19 Pandemic in Japan Hideyuki Terazono, Masami Tsuchiya, Yosuke Maki, Naoki Yoshikawa, Yosuke Kawahara, Keiko Nishimura, et al. (+8)
20 [GO] YAKUGAKU ZASSHI 2022―Mai―31 Development and Evaluation about “2nd-wave” COVID-19 Vaccines Yasuhiro Araki
21 [GO] YAKUGAKU ZASSHI 2022―Mai―31 The Expert of the Medicine Explains “Understanding of the Novel Coronavirus Vaccine” Mariko Takeda-Morishita, Yoshinobu Takakura
22 [GO] YAKUGAKU ZASSHI 2022―Mai―31 What Is an Antibody Test? Characteristics of Antibodies against SARS-CoV-2 and Their Tests Akiko Ishii-Watabe
23 [GO] YAKUGAKU ZASSHI 2022―Mai―31 Compliance with Vaccination against SARS-CoV-2; Information Transmission Based on Scientific Evidence and Its Difficulty Itsuko Ishii
24 [GO] Biological and Pharmaceutical Bulletin 2022―Jan―21 Simultaneous Screening of SARS-CoV-2 Omicron and Delta Variants Using High-Resolution Melting Analysis Akira Aoki, Yoko Mori, Yoshinori Okamoto, Hideto Jinno
25 [GO] YAKUGAKU ZASSHI 2021―Dez―31 Polio Environmental Surveillance and Its Application to SARS-CoV-2 Detection Hiromu Yoshida
26 [GO] Chemical and Pharmaceutical Bulletin 2021―Dez―24 In vitro and in silico studies of potential coronavirus-specific 3C-like protease inhibitors Shoji Maehara, Manami Kobayashi, Mari Kuwada, Tominari Choshi, Hirohumi Inoue, Yuzou Hieda, et al. (+2)
27 [GO] Chemical and Pharmaceutical Bulletin 2021―Dez―20 Application of Acoustic Ejection MS System to High-Throughput Screening for SARS-CoV-2 3CL Protease Inhibitors Tsukasa Hasegawa, Riyo M. Imamura, Tateki Suzuki, Takao Hashiguchi, Takao Nomura, Satoko Otsuguro, et al. (+8)
28 [GO] Biological and Pharmaceutical Bulletin 2021―Jun―30 Remote Reminiscence Using Immersive Virtual Reality May Be Efficacious for Reducing Anxiety in Patients with Mild Cognitive Impairment Even in COVID-19 Pandemic: A Case Report Megumi Yahara, Kazuyuki Niki, Keita Ueno, Mio Okamoto, Takeshi Okuda, Hiroyuki Tanaka, et al. (+4)
29 [GO] Biological and Pharmaceutical Bulletin 2021―Jun―18 Improved detection sensitivity of an antigen test for SARS-CoV-2 nucleocapsid proteins with thio-NAD cycling Yuta Kyosei, Mayuri Namba, Sou Yamura, Satoshi Watabe, Teruki Yoshimura, Tadahiro Sasaki, et al. (+2)
30 [GO] BPB Reports 2021―Mai―25 Verification of MA-T Safety and Efficacy Against Pathogens Including SARS-CoV-2 Takekatsu Shibata, Ryuta Urakawa, Chikako Ono, Yukihiro Akeda, Takayoshi Sakai, Shigeto Hamaguchi, et al. (+5)
31 [GO] Chemical and Pharmaceutical Bulletin 2021―Feb―28 Impact of COVID-19 Outbreak on the Long-Range Transport of Common Air Pollutants in KUWAMS Hao Zhang, Lulu Zhang, Lu Yang, Quanyu Zhou, Xuan Zhang, Wanli Xing, et al. (+3)
 [1] 

31 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec